Products

OncoSpot™ NGS Spike-in Reference Standards

Genecopoeia provides OncoSpot™ NGS Spike-in Reference Standards for monitoring the whole process of the detection. The CRISPR method is employed to modify the genome of tumour cells, introducing single nucleotide mutations or in-frame indel mutations. Concurrently, spike-in markers are set up using our patented technology ‘DNA reference standard and use thereof’.

AccelerRT® 5G Full Length cDNA Synthesis & Amplification Kit

[tab:Product Information] The AccelerRT® 5G Full Length cDNA Synthesis & Amplification Kit can synthesize cDNA ranging from 1-1000 cells or 10 pg - 100 ng of total RNA and an Oligo(dT)VN Primer as a reverse...

DNase I

[tab:Product Information] DNase I is an endonuclease that digests single- and double- stranded DNA. It hydrolyzes phosphodiester bonds producing mono- and oligodeoxyribonucleotides with 5’-phosphate...

T4 DNA Ligase

*Promotions are valid in the US & Canada only. For international customers, please contact your local distributors. Promotion ends October 31, 2025. Discounts are not valid on previous purchases...

Premade antigen microarray

[tab:Introduction] GeneCopoeia's OmicsArray™ antigen microarrays are high-throughput protein microarrays (also known as "protein arrays" or "protein chips") that are powerful tools for many...

CRISPRa/i Stable Cell Lines

GeneHero™ CRISPRa Stable Cell Lines GeneHero™ CRISPRa Stable Cell Lines are mammalian cell lines stably expressing synergistic activation mediators (SAM) for the study of...

No Results Found

The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.